Patent ID: 8932993
Filing Date: 2015-01-13
Classification: C12Q

Abstract:
1. A method of administering an endometriosis altered risk treatment, said method comprising the steps of: identifying an endometriosis asymptomatic human female subject, obtaining clinical data (CD) and a biological sample of said subject, said CD defining the answers to the questions of “menarche after age 14 (Y/N)”, “dysmenorrhea (Y/N)”, and “previous pregnancy (Y/N)”, assigning a raw clinical probability value (RCPV) to said CD, assaying said sample, detecting in said sample a plurality of endometriosis increased risk associated biomarkers, each endometriosis increased risk associated biomarker defining the minor allele of a biomarker of table 1 having an OR of greater than 1.0 resulting in endometriosis increased risk associated biomarker data, performing a statistical analysis using said RCPV and said endometriosis increased risk associated biomarker data to result in an endometriosis condition prognosis of said subject of at least one of an increased risk of endometriosis existence and an increased risk of endometriosis predisposition, and administering an endometriosis altered risk treatment to said subject, said endometriosis altered risk treatment defining a hormonal treatment comprising the administration of at least one of an estrogen containing composition, a progesterone containing composition, a progestin containing composition, a testosterone containing composition, a gonadotropin releasing-hormone (GnRH) agonist, and a combination thereof.